Literature DB >> 28789422

Selective surface marker and miRNA profiles of CD34+ blast-derived microvesicles in chronic myelogenous leukemia.

Junli Zhang1,2, Aiqi Zhao1, Li Sun1,3, Weiqun Chen4, Haiming Zhang5, Zhichao Chen1, Fang Liu1.   

Abstract

The present study aimed at investigating the selective enrichment of surface marker and functional microRNA (miRNA) profiles of cluster of differentiation (CD)34+ blast-derived microvesicles (MVs) from parental cells in chronic myelogenous leukemia (CML), thus providing an experimental basis for MVs to be used to predict characteristics of CD34+ blasts. Magnetic activated cell sorting and continuous differential centrifugation were used to isolate primary CML CD34+ blasts and MVs, in addition to utilizing flow cytometry to identify surface markers of CD34+ blasts and blast-derived MVs. Microarray analysis and the reverse transcription-quantitative polymerase chain reaction were performed to analyze miRNA profiles of CD34+ blasts and MVs. The results of the present study indicated that primary CML CD34+ blasts were able to release MVs, which were selectively enriched with the surface markers CD34 and CD123, and functional miRNAs from parental cells. A total of 15 miRNAs were upregulated in CD34+ blast derived-MVs compared with in CD34+ cells. Distinct Kyoto Encyclopedia of Genes and Genomes pathways and Gene Ontology terms characterized by altered gene expression and potentially associated miRNA were identified. Upregulated miRNAs in MVs were associated with cell development, tumorigenesis and signaling pathways involving ErbB and phosphoinositide 3-kinase/protein kinase B. The present study provides evidence, which increases the understanding of physiological functions of cancer-derived MVs, and aids the understanding of the roles of CD34+ blast-derived MVs in CML-associated processes.

Entities:  

Keywords:  chronic myelogenous leukemia; cluster of differentiation 123; cluster of differentiation 34+ blasts; microRNA; microvesicles

Year:  2017        PMID: 28789422      PMCID: PMC5529767          DOI: 10.3892/ol.2017.6336

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.

Authors:  Li Sun; Hong-xiang Wang; Xiao-jian Zhu; Pin-hui Wu; Wei-qun Chen; Ping Zou; Qiu-bai Li; Zhi-chao Chen
Journal:  Acta Pharmacol Sin       Date:  2013-12-30       Impact factor: 6.150

3.  CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.

Authors:  David Gonzalez; Monica Else; Dorte Wren; Monica Usai; Anne Mette Buhl; Anton Parker; David Oscier; Gareth Morgan; Daniel Catovsky
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

4.  Exosomal microRNAs as potential biomarkers in castration-resistant prostate cancer.

Authors:  Benedikta S Haflidadóttir; Yvonne Ceder
Journal:  Eur Urol       Date:  2014-09-06       Impact factor: 20.096

5.  Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells.

Authors:  Vincenzo Cantaluppi; Stefano Gatti; Davide Medica; Federico Figliolini; Stefania Bruno; Maria C Deregibus; Andrea Sordi; Luigi Biancone; Ciro Tetta; Giovanni Camussi
Journal:  Kidney Int       Date:  2012-04-11       Impact factor: 10.612

6.  TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

Authors:  Kazuhito Naka; Takayuki Hoshii; Teruyuki Muraguchi; Yuko Tadokoro; Takako Ooshio; Yukio Kondo; Shinji Nakao; Noboru Motoyama; Atsushi Hirao
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

7.  miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.

Authors:  Christian Philipp Pallasch; Michaela Patz; Yoon Jung Park; Susanne Hagist; Daniela Eggle; Rainer Claus; Svenja Debey-Pascher; Alexandra Schulz; Lukas P Frenzel; Julia Claasen; Nadine Kutsch; Günter Krause; Christine Mayr; Andreas Rosenwald; Christoph Plass; Joachim L Schultze; Michael Hallek; Clemens-Martin Wendtner
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

8.  Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells.

Authors:  Eva Nievergall; Hayley S Ramshaw; Agnes S M Yong; Mark Biondo; Samantha J Busfield; Gino Vairo; Angel F Lopez; Timothy P Hughes; Deborah L White; Devendra K Hiwase
Journal:  Blood       Date:  2013-12-20       Impact factor: 22.113

9.  Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway.

Authors:  Wei-Zhang Wang; Qiao-Hong Pu; Xiang-Hua Lin; Man-Yu Liu; Li-Rong Wu; Qing-Qing Wu; Yong-Heng Chen; Fen-Fang Liao; Jia-Yong Zhu; Xiao-Bao Jin
Journal:  Leuk Res       Date:  2015-07-21       Impact factor: 3.156

Review 10.  Extracellular vesicles: exosomes, microvesicles, and friends.

Authors:  Graça Raposo; Willem Stoorvogel
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

View more
  4 in total

Review 1.  The biology of extracellular microvesicles.

Authors:  Alanna E Sedgwick; Crislyn D'Souza-Schorey
Journal:  Traffic       Date:  2018-03-25       Impact factor: 6.215

Review 2.  Matrix Vesicles as a Therapeutic Target for Vascular Calcification.

Authors:  Tiantian Li; Hongchi Yu; Demao Zhang; Tang Feng; Michael Miao; Jianwei Li; Xiaoheng Liu
Journal:  Front Cell Dev Biol       Date:  2022-01-21

Review 3.  Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.

Authors:  Lia Walcher; Ann-Kathrin Kistenmacher; Huizhen Suo; Reni Kitte; Sarah Dluczek; Alexander Strauß; André-René Blaudszun; Tetyana Yevsa; Stephan Fricke; Uta Kossatz-Boehlert
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

Review 4.  The "Vesicular Intelligence" Strategy of Blood Cancers.

Authors:  Dorian Forte; Martina Barone; Francesca Palandri; Lucia Catani
Journal:  Genes (Basel)       Date:  2021-03-13       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.